Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy

Creative Commons License

Tonelli A. R., Haserodt S., Aytekin M., Dweik R. A.

PULMONARY CIRCULATION, cilt.3, sa.1, ss.20-30, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 3 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.4103/2045-8932.109911
  • Dergi Adı: PULMONARY CIRCULATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.20-30
  • Erciyes Üniversitesi Adresli: Evet

Özet

Nitric oxide (NO) is a diffusible gas with diverse roles in human physiology and disease. Significant progress in the understanding

of its biological effects has taken place in recent years. This has led to a better understanding of the pathobiology of pulmonary

hypertension (PH) and the development of new therapies. This article provides an overview of the NO physiology and its role

in the pathobiology of lung diseases, particularly PH. We also discuss current and emerging specific treatments that target NO

signaling pathways in PH.